Mindray's BeneVision N-Series is the first patient monitoring platform to integrate Edwards' FloTrac™ sensor technology to offer greater insights into advanced hemodynamic monitoring to manage ...
TOKYO, Jan. 25 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation , a global leader in hemodynamic monitoring technologies, announced that it has received ...
Jan. 31, 2006 -- A dual-chamber implantable cardioverter defibrillator has been released on the European market following approval by the European Commission (EC) last year; the EC has approved an ...
BRUSSELS, Belgium, March 22 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), a global leader in hemodynamic monitoring technologies, announced the European launch of its Edwards FloTrac(TM ...
We read with great interest the meta-analysis by Alves et al.,(1)who highlighted the effects of goal-directed therapy (GDT) guided by the FloTrac sensor in patients undergoing major surgery. This meta ...
일부 결과는 사용자가 액세스할 수 없으므로 숨겨졌습니다.
액세스할 수 없는 결과 표시
피드백